Trials / Completed
CompletedNCT00473655
Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients
A Double-blind, Double Dummy, Phase IV, Randomized, Multicenter, Parallel Group, Placebo Controlled Trial to Evaluate the Effect of Rosuvastatin on Triglycerides Levels in Mexican Hypertriglyceridemic Patients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 334 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this trial is to determine if the treatment with rosuvastatin 10 and 20mg/day during 8 weeks in hypertriglyceridemic patients will reduce their triglyceride levels.
Conditions
- Hypertriglyceridemia
- Hyperlipoproteinemia Type IV
- Hyperlipoproteinemia Type V
- Hyperlipoproteinemia Type IIb
- Hyperlipidemia
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | rosuvastatin | 10mg or 20mg |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2007-05-15
- Last updated
- 2010-12-16
- Results posted
- 2010-06-08
Locations
3 sites across 1 country: Mexico
Source: ClinicalTrials.gov record NCT00473655. Inclusion in this directory is not an endorsement.